• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

A Study of Nucleated Red Blood Cell count as a Prognostic Marker for Adverse outcome in Neonatal Sepsis

    Dr. Venu Kota, Dr.Aruna Rekha Neela, Dr.Suresh Babu Mendu, Dr.Subhan Basha Bukkapatnam

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 3030-3035

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Neonatal Sepsis is the major cause of neonatal mortality among developing countries, the diagnosis of which depends on blood culture, which has low sensitivity and takes time.
Aim & Objective : To know whether Nucleated red blood cell count can be the first prognostic marker for adverse outcome in neonatal sepsis.
Materials and method: This was a hospital based prospective study conducted among neonates with clinical feature of  sepsis in department of paediatrics, Govt Medical College, Siddipet, Telangana State, for the duration of one year. 50 patients were selected for the study after getting their informed consent and following inclusion and exclusion criteria, the maternal details and examination findings were recorded and blood sample taken for sepsis screen, blood culture and peripheral smear for NRBC.
Results: Sensitivity of NRBC in identifying sepsis was 86.9%, its specificity was 69.3%, positive predictive value was 74.2%, and negative predictive value was 77.56%, with cut off value of 16.4. Also study observed 6/26(23%) mortality among neonates with sepsis. And its was 12% among all study samples.
Conclusion: NRBC is significantly elevated in the neonatal sepsis and  it can be predictor of adverse neonatal outcome.
Keywords:
    NRBC Peripheral Smear Blood Culture etc
  • PDF (262 K)
  • XML
(2023). A Study of Nucleated Red Blood Cell count as a Prognostic Marker for Adverse outcome in Neonatal Sepsis. European Journal of Molecular & Clinical Medicine, 9(2), 3030-3035.
Dr. Venu Kota, Dr.Aruna Rekha Neela, Dr.Suresh Babu Mendu, Dr.Subhan Basha Bukkapatnam. "A Study of Nucleated Red Blood Cell count as a Prognostic Marker for Adverse outcome in Neonatal Sepsis". European Journal of Molecular & Clinical Medicine, 9, 2, 2023, 3030-3035.
(2023). 'A Study of Nucleated Red Blood Cell count as a Prognostic Marker for Adverse outcome in Neonatal Sepsis', European Journal of Molecular & Clinical Medicine, 9(2), pp. 3030-3035.
A Study of Nucleated Red Blood Cell count as a Prognostic Marker for Adverse outcome in Neonatal Sepsis. European Journal of Molecular & Clinical Medicine, 2023; 9(2): 3030-3035.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 7
  • PDF Download: 24
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus